Monthly Archives: October 2010

Number of diabetic Americans could triple by 2050

October 29th, 2010 (No Comments)

As many as 1 in 3 U.S. adults could have diabetes by 2050, federal officials recently announced. The Centers for Disease Control and Prevention (CDC) estimate that 1 in 10 have diabetes now – approximately 24 million Americans – but that number could grow to 1 in 5 or even 1 in 3 by mid-century if current trends continue.

Anticipating approval from a renowned scholar

October 26th, 2010 (No Comments)

When Charles Raison hosted a fundraising dinner for Jestun Pema, the sister of His Holiness the Dalai Lama some years ago as a faculty member at the University of California at Los Angeles, little did he know his future would become intertwined with His Holiness.

New Emory center expands diabetes prevention

October 19th, 2010 (No Comments)

According to the CDC, an estimated 23.6 million Americans live with diabetes. The Diabetes Training and Technical Assistance Center (DTTAC), based at the Rollins School of Public Health, aims to reduce the burden of the disease. Established with a $2 million grant from the CDC’s Division of Diabetes Translation, DTTAC is modeled after the Tobacco […]

Shedding light on the vitamin D-Parkinson’s connection

October 18th, 2010 (No Comments)

Vitamin D may be called a vitamin, but it’s not. That’s because we can make it by exposing our skin to sunshine. So, technically that makes vitamin D a hormone–a steroid hormone to be exact. In fact, we get most of our exposure to vitamin D directly from sunshine and some from foods such as […]

A path to treatment of lymphedema

October 13th, 2010 (No Comments)

Lymphedema, or swelling because of the impaired flow of lymph fluid, can occur as a consequence of cancer or cancer treatment. Chemotherapy can damage lymph ducts, and often surgeons remove lymph nodes that may be affected by cancer metastasis. Lymphedema can result in painful swelling, impaired mobility and changes in appearance. Emory scientists, led by […]

Adjuvants: once immunologists’ “dirty little secret”

October 8th, 2010 (No Comments)

Two presentations on Emory research at last week’s AIDS Vaccine 2010 conference concerned adjuvants. These are substances that act as amplifiers, stimulating the immune system while keeping its focus on the specific components of a vaccine.

What if HIV was just another virus

October 7th, 2010 (No Comments)

Imagine that HIV was a “normal” virus. An infection begins and the body responds, without getting trapped in a cycle where CD4+ T cells are consumed and the immune system is crippled.